The 6th Annual Clinical Care Options Hepatitis Symposium is designed for participants to synthesize the advancements of the previous year and to discuss state-of-the-art treatment strategies with leading experts and colleagues in a setting that is conducive to both formal learning and informal networking.
Agenda
THURSDAY, MAY 29, 2008
12:00 PM - 6:00 PM – Registration
6:00 PM - 10:00 PM – Welcome Reception
FRIDAY, MAY 30, 2008
7:00 AM – Continental Breakfast
New this year: Interact informally with selected faculty at topic-based “breakfast with the faculty” tables
7:45 AM – Plenary Session
Welcome, Opening Remarks, and Day 1 Overview
Co-Chair: Marion G. Peters, MD, FRACP
8:00 AM
Can Hepatitis B Be Cured?
Speaker: Marc G. Ghany, MD
Bethesda, Maryland
8:20 AM
Therapy of Chronic Hepatitis B: Who to Treat and When to Treat (30 minutes)
Speaker: Anna S. F. Lok, MD
Ann Arbor, Michigan
8:50 AM – Break
9:10 AM
Therapy of Chronic Hepatitis B: What to Choose, When to Stop, and When to Change
Speaker: Ira M. Jacobson, MD
New York, New York
9:50 AM
Case-Based Plenary: Approach to Women With Hepatitis B Who Are Pregnant or Anticipating Pregnancy
Speaker: Tram T. Tran, MD
Los Angeles, California
10:20 AM – Panel
Questions on Morning Plenary Topics
Panelists: Morning speakers
11:00 AM – Break
11:30 AM – 1:00 pm
Interactive Case Challenges 1: HBV
Co-Chair: Marion G. Peters, MD, FRACP
Discussants: Raymond T. Chung, MD; Jules L. Dienstag, MD; Ira M. Jacobson, MD; Anna S. F. Lok, MD
- Approach to the Hepatitis B Patient With Normal ALT
- Managing Hepatitis B in a Cancer/Chemotherapy Patient: When to Start, How Long to Treat, What Therapy?
- Management of a Patient With Suboptimal Response to Anti-HBV Therapy: Switch vs Combination?
1:00 PM – Lunch
Afternoon/Evening
Leisure Activities and Dinner
(on your own)
SATURDAY, MAY 31, 2008
7:00 AM – Continental Breakfast
7:45 AM – Plenary Session
Day 2 Overview
Co-Chair: Mark S. Sulkowski, MD
8:00 AM
New Data on Currently Available HCV Therapies and Their Impact on Initial Treatment Strategies
Speaker: Mark S. Sulkowski, MD
Baltimore, Maryland
8:30 AM
Case-Based Plenary: Maximizing HCV Treatment in Persons With Substance Abuse and Mental Illness
Speaker: Edmund J. Bini, MD, MPH
New York, New York
9:00 AM – Break
9:20 AM
Strategies for Management of Hepatitis C Treatment Failure
Speaker: Karen L. Lindsay, MD, MMM
Los Angeles, California
9:50 AM
HCV Therapy: What Will the Future Look Like?
Speaker: David R. Nelson, MD
Gainesville, Florida
10:20 AM – Panel
Questions on Morning Plenary Topics
Co-Chair: Mark S. Sulkowski, MD
Panelists: Morning speakers
11:00 AM – Break
11:30 AM – 1:00 PM
Interactive Case Challenges 2: HCV
Co-Chair: Adrian Di Bisceglie, MD, FACP
Discussants: Karen L. Lindsay, MD, MMM; David R. Nelson, MD; Mark S. Sulkowski, MD
- Management of an Obese Patient With Chronic Hepatitis C
- Use of Growth Factors During Peginterferon/Ribavirin therapy
- Management of Renal Insufficiency in Hepatitis C
1:00 PM – Lunch
Afternoon/Evening
Leisure Activities and Dinner
(on your own)
SUNDAY, JUNE 1, 2008
7:45 AM – Breakfast
8:30 AM– Plenary Sesssion
Day 3 Overview
Co-Chair: Raymond T. Chung, MD
8:45 AM
Update on Autoimmune Hepatitis: Management Strategies
Speaker: Michael P. Manns, MD
Hanover, Germany
9:15 AM
Managing the Complications of Decompensated Cirrhosis
Speaker: Guadalupe Garcia-Tsao, MD
New Haven, Connecticut
9:45 AM
Hepatitis Journal Club: Top Clinical Articles of 2007-2008
Speaker: Jorge L. Herrera, MD
Mobile, Alabama
10:15 am – Panel
Questions on Morning Plenary Topics
Co-Chair: Raymond T. Chung, MD
Panelists: Morning speakers
10:30 AM
Closing Remarks
Co-Chair:Raymond T. Chung, MD
10:45 AM - Adjournment